Xiaobo Zhong

2.1k total citations
59 papers, 706 citations indexed

About

Xiaobo Zhong is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Xiaobo Zhong has authored 59 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 21 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Xiaobo Zhong's work include Multiple Myeloma Research and Treatments (19 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Xiaobo Zhong is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Xiaobo Zhong collaborates with scholars based in United States, United Kingdom and France. Xiaobo Zhong's co-authors include Dawn L. Hershman, Alfred I. Neugut, Jason D. Wright, Shing M. Lee, Parameswaran Hari, Hanina Hibshoosh, Eileen P. Connolly, Mary Eapen, Melissa Accordino and Jingyan Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Xiaobo Zhong

50 papers receiving 703 citations

Peers

Countries citing papers authored by Xiaobo Zhong

Since Specialization

Citations

This map shows the geographic impact of Xiaobo Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Zhong more than expected).

Fields of papers citing papers by Xiaobo Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Zhong. The network helps show where Xiaobo Zhong may publish in the future.

Co-authorship network of co-authors of Xiaobo Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Zhong. A scholar is included among the top collaborators of Xiaobo Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Zhong. Xiaobo Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Knowledge, attitudes and practices towards blood donation among donors: a cross-sectional study in Shaoxing, Zhejiang, China 2025 ·BMJ Open ·Lingling Jiang, Xiaobo Zhong, (unknown), (unknown), Yuan Fang, Nuo Li, Haiyan Luo	0
2	MM-493 Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) With Lenalidomide (R) Maintenance Versus R Maintenance Alone in Adult Patients With Newly Diagnosed Multiple Myeloma (NDMM) Who Have Suboptimal Response to Autologous Stem Cell Transplantation (ASCT): Phase 3 KarMMa-9 Trial 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Noopur Raje, Adam D. Cohen, (unknown), Shaji Kumar, Aurore Perrot, Fredrik Schjesvold, Hermann Einsele, Paula Rodríguez‐Otero, (unknown), Carlos Fernández de Larrea, (unknown), Anna Truppel-Hartmann, (unknown), Fan Wu, Xiaobo Zhong, (unknown), Mihaela Popa, Mark Cook, María-Victoria Mateos	1
3	Global Manufacturing Experience with Idecabtagene Vicleucel in Patients with Relapsed and Refractory Multiple Myeloma 2024 ·Blood ·Surbhi Sidana, Christof Scheid, (unknown), Petra Schuberth, Hardik Modi, (unknown), Romain Piault, Xiaobo Zhong, Paula Rodríguez‐Otero	0
4	Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis 2022 ·Discover Oncology ·Qian Qin, Tomi Jun, Bo Wang, Vaibhav G. Patel, (unknown), Xiaobo Zhong, (unknown), (unknown), Amanda Leiter, Emily J. Gallagher, (unknown), Philip Garcia, Himanshu Joshi, (unknown), Matthew D. Galsky, William Oh, Che‐Kai Tsao	6
5	Neighborhood disparities in COVID-19 outcomes in New York city over the first two waves of the outbreak 2022 ·Annals of Epidemiology ·Xiaobo Zhong, Ziqi Zhou, Guohua Li, (unknown), Peter Muennig, Qixuan Chen	7
6	Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors 2022 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Vaibhav G. Patel, Xiaobo Zhong, Himanshu Joshi, (unknown), Bo Wang, (unknown), Tomi Jun, (unknown), Philip Garcia, (unknown), Amanda Leiter, Emily J. Gallagher, William Oh, Matthew D. Galsky, Che‐Kai Tsao	15
7	Development and Validation of a Functionally Relevant Comorbid Health Index in Adults Admitted to Inpatient Rehabilitation for Traumatic Brain Injury 2021 ·Journal of Neurotrauma ·Raj G. Kumar, Xiaobo Zhong, Gale G. Whiteneck, Madhu Mazumdar, Flora M. Hammond, Natalia Egorova, (unknown), Kristen Dams-O’Connor	2
8	Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? 2021 ·Clinical Genitourinary Cancer ·(unknown), Qian Qin, Xiaobo Zhong, Justin Lin, Matthew D. Galsky, William Oh, Che‐Kai Tsao	1
9	Are women underrepresented in cerebrovascular disease clinical trials? A systematic review using the FDA database 2020 ·medRxiv ·Xiaobo Zhong, Qing Hao	0
10	A New Transcranial Doppler Scoring System for Evaluating Middle Cerebral Artery Stenosis 2019 ·Journal of Neuroimaging ·Qing Hao, Edward Feldmann, Clotilde Balucani, Nicole Zubizarreta, Xiaobo Zhong, Steven R. Levine	0
11	Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial 2018 ·Clinical & Translational Oncology ·Kevin Kalinsky, Joseph A. Sparano, Xiaobo Zhong, Eleni Andreopoulou, Bret Taback, Lisa Wiechmann, Sheldon Feldman, Preya Ananthakrishnan, Aqeel Ahmad, Serge Cremers, Anthony Sireci, Justin R. Cross, Douglas K. Marks, Prabhjot S. Mundi, Eileen P. Connolly, Katherine D. Crew, Matthew Maurer, Hanina Hibshoosh, Stephen A. Lee, (unknown)	19
12	Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis 2017 ·Clinical Breast Cancer ·Ying L. Liu, Christine Choi, Shing M. Lee, Xiaobo Zhong, Hanina Hibshoosh, Kevin Kalinsky, Eileen P. Connolly	13
13	Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL) 2016 ·Breast Cancer Research and Treatment ·Dawn L. Hershman, Lawrence H. Kushi, Grace Clarke Hillyer, Ellie J. Coromilas, Donna Buono, Lois Lamerato, Dana H. Bovbjerg, Jeanne S. Mandelblatt, Wei‐Yann Tsai, Xiaobo Zhong, Judith S. Jacobson, Jason D. Wright, Alfred I. Neugut	51
14	Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy 2016 ·Breast Cancer Research and Treatment ·Ying L. Liu, Anurag Saraf, Shing M. Lee, Xiaobo Zhong, Hanina Hibshoosh, Kevin Kalinsky, Eileen P. Connolly	50
15	Allergic sensitization patterns identified through latent class analysis among children with and without asthma 2016 ·Annals of Allergy Asthma & Immunology ·Qixuan Chen, Xiaobo Zhong, Luis Acosta, Adnan Divjan, Andrew Rundle, Inge F. Goldstein, Rachel L. Miller, Matthew S. Perzanowski	10
16	Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation 2015 ·Bone Marrow Transplantation ·Robert F. Cornell, Xiaobo Zhong, Carlos Arce‐Lara, Ehab Atallah, (unknown), William R. Drobyski, Timothy S. Fenske, (unknown), J. Douglas Rizzo, Wael Saber, Parameswaran Hari	21
17	Prevalence of Sexual Experience and Initiation of Sexual Intercourse Among Adolescents, Rakai District, Uganda, 1994–2011 2015 ·Journal of Adolescent Health ·John Santelli, Xiaoyu Song, Inge K. Holden, (unknown), Xiaobo Zhong, Ying Wei, Sanyukta Mathur, Tom Lutalo, Fred Nalugoda, Ron Gray, David Serwadda	11
18	Partner Characteristics Associated With HIV Acquisition Among Youth in Rakai, Uganda 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Sanyukta Mathur, Ying Wei, Xiaobo Zhong, Xiaoyu Song, Fred Nalugoda, Tom Lutalo, Maria J. Wawer, Ron Gray, David Serwadda, John Santelli	10
19	Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis 2014 ·Biology of Blood and Marrow Transplantation ·Daniel Weisdorf, Mary Eapen, Annalisa Ruggeri, Mei-Jie Zhang, Xiaobo Zhong, Claudio G. Brunstein, Celalettin Üstün, Vanderson Rocha, Éliane Gluckman	60
20	Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma 2014 ·Biology of Blood and Marrow Transplantation ·Ravi Vij, Shaji Kumar, Mei-Jie Zhang, Xiaobo Zhong, Jiaxing Huang, Angela Dispenzieri, Muneer H. Abidi, Jennifer M. Bird, César O. Freytes, Robert Peter Gale, Tamila L. Kindwall‐Keller, Robert A. Kyle, Daniel J. Landsburg, Hillard M. Lazarus, Reinhold Munker, Vivek Roy, Manish Sharma, Dan T. Vogl, Baldeep Wirk, Parameswaran Hari	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact